28 Pa. Code § 1151a.29. Limit on medical marijuana processing.

§ 1151a.29. Limit on medical marijuana processing.

(a)  In the form intended to be sold to another medical marijuana organization, medical marijuana or a medical marijuana product must have a specific concentration of total THC and total CBD and must have a consistent cannabinoid profile. The concentration of the following cannabinoids shall be reported to the Department by an approved laboratory and include the following on the label (CAS numbers need not be displayed on the label):
   (1)  THC.
   (2)  THCA, if greater than 0.0%.
   (3)  THCV, if greater than 0.0%.
   (4)  CBD.
   (5)  CBDA, if greater than 0.0%.
   (6)  CBDV, if greater than 0.0%.
   (7)  CBN, if greater than 0.0%.
   (8)  CBG, if greater than 0.0%.
   (9)  CBC, if greater than 0.0%.
   (10)  D8, if greater than 0.0%.
   (11)  Any other cannabinoid component at 0.1%.
(b)  Within the first 6 months after the Department determines the grower/processor to be operational, the grower/processor shall provide the Department with a forecast of the amount of medical marijuana products it projects it will produce and in what form. The grower/processor shall notify the Department in writing within 48 hours upon becoming aware of a potential increase or decrease in the forecasted amount occurring within any subsequent 6-month period.

Cross References

   This section cited in 28 Pa. Code §  1151a.34 (relating to packaging and labeling of medical marijuana products); and 28 Pa. Code §  1161a.28 (relating to labels and safety inserts).

No part of the information on this site may be reproduced for profit or sold for profit.

This material has been drawn directly from the official Pennsylvania Code full text database. Due to the limitations of HTML or differences in display capabilities of different browsers, this version may differ slightly from the official printed version.